CDKN2A and central nervous system cancer: Moreover, the homozygous deletion of CDKN2A/B, which was recognized as an indicator for more malignant biological behaviors in gliomas, was significantly more frequently observed in cluster 2 (Figure 3F), in line with the survival analysis.